Skip to content
    • About the Library
    • Rules and Regulations
    • Library Services
    • Library Hours
  • Library News
    • Digital Repository
    • Google Scholar
    • ResearchGate
    • AJoGPL
    • KURJ
    • AJLS
    • MyLOFT
    • Lexis Plus UK
    • Britannica Academic
    • Research Support Tools
    • Quick Resource Links
  • Login
Advanced
  • First experience in treating a...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Save to List
  • Permanent link
First experience in treating advanced urothelial cancer with enfortumab vedotin. Single-centre retrospective study of patients qualified for a rescue access procedure

First experience in treating advanced urothelial cancer with enfortumab vedotin. Single-centre retrospective study of patients qualified for a rescue access procedure

Saved in:
Bibliographic Details
Main Authors: Bożena Sikora-Kupis, Piotr Domański, Weronika Fortuniak, Barbara Kruczyk, Szymon Staneta, Mateusz Piętak, Anna Mydlak, Tomasz Demkow, Paulina Dumnicka, Jakub Kucharz
Format: Article
Language:English
Published: Termedia Publishing House 2024-01-01
Series:Contemporary Oncology
Subjects:
advanced urothelial cancer
enfortumab vedotin (ev)
antibody-drug conjugates (adc)
toxicity
Online Access:https://www.termedia.pl/First-experience-in-treating-advanced-urothelial-cancer-with-enfortumab-vedotin-Single-centre-retrospective-study-of-patients-qualified-for-a-rescue-access-procedure,3,52310,1,1.html
Tags: Add Tag
No Tags, Be the first to tag this record!
  • Holdings
  • Description
  • Comments
  • Similar Items
  • Staff View

Internet

https://www.termedia.pl/First-experience-in-treating-advanced-urothelial-cancer-with-enfortumab-vedotin-Single-centre-retrospective-study-of-patients-qualified-for-a-rescue-access-procedure,3,52310,1,1.html

Similar Items

  • Efficacy of modified enfortumab vedotin ineligible criteria (mEVITA) in advanced urothelial carcinoma
    by: Takafumi Fukushima, et al.
    Published: (2025-07-01)
  • Dramatic Response to Enfortumab Vedotin in Soft-tissue Metastases from Urothelial Carcinoma: A Case Report
    by: Ming-Hsuan Wu, et al.
    Published: (2024-12-01)
  • Enfortumab Vedotin–Induced Toxic Epidermal Necrolysis in Metastatic Urothelial Carcinoma Complicated by Severe Gastrointestinal Bleeding
    by: Aika Matsuyama, et al.
    Published: (2025-07-01)
  • Strategies to overcome resistance to enfortumab vedotin and pembrolizumab for patients with urothelial carcinoma: harnessing present knowledge for future advances
    by: Albert Jang, et al.
    Published: (2025-04-01)
  • Mechanistic Insights and Future Directions for Enfortumab Vedotin in Urothelial Carcinoma: Highlights from the 10th Annual Leo & Anne Albert Institute for Bladder Cancer Care and Research Symposium
    by: Catherine C. Fahey, et al.
    Published: (2025-05-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs